Vol. 149, No. 10 — May 20, 2015
SOR/2015-101 May 5, 2015
Regulations Amending the Pari-Mutuel Betting Supervision Regulations
The Minister of Agriculture and Agri-Food, pursuant to subsection 204(9) (see footnote a) of the Criminal Code (see footnote b), makes the annexed Regulations Amending the Pari-Mutuel Betting Supervision Regulations.
Ottawa, May 4, 2015
Minister of Agriculture and Agri-Food
REGULATIONS AMENDING THE PARI-MUTUEL BETTING SUPERVISION REGULATIONS
1. Paragraph 1(d) of the schedule to the Pari-Mutuel Betting Supervision Regulations (see footnote 1) is amended by adding the following in alphabetical order:
- Buprenorphine (Buprénorphine)
COMING INTO FORCE
2. These Regulations come into force on the day on which they are registered.
REGULATORY IMPACT ANALYSIS STATEMENT
(This statement is not part of the Regulations.)
The Pari-Mutuel Betting Supervision Regulations (the Regulations) are designed to protect the integrity of pari-mutuel betting on horse races authorized under section 204 of the Criminal Code. Drugs and medications administered to race horses could affect the outcome of a pari-mutuel race. Drugs that are veterinary medications approved for sale in Canada may be administered to a horse but, with few exceptions, including vitamins and some anti-parasitic and antimicrobial agents, must not be present in a horse’s system when it races.
This amendment adds the drug Buprenorphine to section 1 of the schedule of drugs to the Regulations.
There are no appropriate alternatives.
Benefits and costs
The impact of this amendment will be positive because the prohibition of a potentially performance-altering drug will continue to protect the bettors, the integrity of the racing industry, and the credibility of the Canadian Pari-Mutuel Agency’s (CPMA) Equine Drug Control Program.
There are no significant costs or environmental impact associated with this regulatory amendment.
The CPMA consults with the Federal Drug Advisory Committee, consisting of veterinarians, pharmacologists and chemists, when proposing to add a drug to the schedule. The Committee supports this regulatory action.
Provincial racing commissions continue to endorse the CPMA’s Equine Drug Control Program, including the maintenance of the schedule of prohibited drugs.
Compliance and enforcement
Information on additions to the schedule is provided to all industry sectors, so that they know which substances to avoid when treating horses scheduled to race.
Compliance with the CPMA’s Equine Drug Control Program is accomplished by the testing of post-race samples of urine or blood taken from race horses. Positive results are reported to the provincial racing commissions for appropriate action under their rules of racing.
This amendment will not increase the current requirements for compliance and enforcement activities.
Research and Analysis
Canadian Pari-Mutuel Agency
Agriculture and Agri-Food Canada
P.O. Box 5904, LCD Merivale